BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3566848)

  • 21. Oral medium-dosed metoclopramide versus placebo as highly effective antiemetic prophylaxis in in- and outpatients on noncisplatin chemotherapy.
    Vogt C; Hellenbrecht D; Saller R; Achtert G; Brockmann P; Hausleiter H
    Oncology; 1993; 50(2):81-5. PubMed ID: 8451040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cisplatin-induced emesis in dogs with malignant neoplasia: 115 cases (1984-1987).
    Ogilvie GK; Moore AS; Curtis CR
    J Am Vet Med Assoc; 1989 Nov; 195(10):1399-403. PubMed ID: 2584105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation.
    Saller R; Hellenbrecht D; Bühring M; Hess H
    J Clin Pharmacol; 1986 Feb; 26(2):115-9. PubMed ID: 3512620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis.
    Pollera CF; Conti EM; De Nigris A; Calabresi F
    Oncology; 1987; 44(2):73-7. PubMed ID: 3554084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
    Aasebø U; Slørdal L; Prytz PS; Aarbakke J
    Pharmacol Toxicol; 1987 May; 60(5):337-9. PubMed ID: 3303001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous infusion of high-dose metoclopramide: comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis.
    Brechot JM; Dupeyron JP; Delattre C; Chastang C; Laaban JP; Rochemaure J
    Eur J Clin Pharmacol; 1991; 40(3):283-6. PubMed ID: 1647955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
    Saller R; Hellenbrecht D; Briemann L; Hellstern A; Hess H; Mitrou P; Hodgson M; Achtert G; Brockmann P; Hausleiter HJ
    Clin Pharmacol Ther; 1985 Jan; 37(1):43-7. PubMed ID: 4038385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing metoclopramide control of cisplatin-induced emesis.
    Meyer BR; Lewin M; Drayer DE; Pasmantier M; Lonski L; Reidenberg MM
    Ann Intern Med; 1984 Mar; 100(3):393-5. PubMed ID: 6538075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin.
    Tonato M; Roila F; del Favero A; Tognoni G; Franzosi MG; Pampallona S
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):807-10. PubMed ID: 4043169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does parenteral magnesium sulfate have an antiemetic effect during chemotherapy with cis-platinum?
    Ballmer PE; Reinhart WH
    Cancer Chemother Pharmacol; 1989; 24(2):109-12. PubMed ID: 2731311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single dose of metoclopramide in the control of vomiting from cis-dichlorodiammineplatinum(II) in man.
    Kahn T; Elias EG; Mason GR
    Cancer Treat Rep; 1978 Jul; 62(7):1106-7. PubMed ID: 688250
    [No Abstract]   [Full Text] [Related]  

  • 32. Dystonic reactions with metoclopramide: is there a risk population?
    Boulloche J; Mallet E; Mouterde O; Tron P
    Helv Paediatr Acta; 1987 Jun; 42(5-6):425-32. PubMed ID: 3454349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of metoclopramide in treatment of cisplatin-induced emesis.
    Richtsmeier WJ; Mazur EM
    Otolaryngol Head Neck Surg; 1986 Oct; 95(3 Pt 1):358-9. PubMed ID: 3108786
    [No Abstract]   [Full Text] [Related]  

  • 34. [Metoclopramide (Cerucal) side-effects in the form of extrapyramidal disorders in combination with an other antidepressive agent].
    Ficker F; Felber W
    Psychiatr Neurol Med Psychol (Leipz); 1977 May; 29(5):304-6. PubMed ID: 882611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Extrapyramidal type collateral effects of the administration of metoclopramide to children].
    Bruni L; Funaro G; Grilli MA; Bernardi S; Tozzi MC
    Pediatr Med Chir; 1989; 11(3):317-8. PubMed ID: 2594559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial dyskinesia following single dose metoclopramide.
    Tongia SK; Bhagwat AW
    J Assoc Physicians India; 1990 Oct; 38(10):815-6. PubMed ID: 2084100
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetic studies of high-dose metoclopramide with and without forced diuresis.
    Ell C; Braun J; König HJ; Domschke S; Domschke W
    Klin Wochenschr; 1985 Jun; 63(12):572-4. PubMed ID: 3928960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extrapyramidal syndrome as a side-effect of treatment with thiethylperazine (torecan) and metoclopramide (Reglan) a review of ten cases (author's transl)].
    Babić K; Borcić D; Beus A
    Lijec Vjesn; 1977 Mar; 99(3):181-4. PubMed ID: 875594
    [No Abstract]   [Full Text] [Related]  

  • 39. [Extrapyramidal disorders occurring after taking cerucal].
    Il'iash TI; Laskarzhevskaia NM
    Vrach Delo; 1991 Oct; (10):117-8. PubMed ID: 1803734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Letter: Extrapyramidal syndrome and metoclopramide].
    Khalil R; Ali Cherif A; Vigouroux RA; Boudouresques G
    Nouv Presse Med; 1976 Jun; 5(24):1536-7. PubMed ID: 940747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.